NIFTY 50▼23,995.35
-309.00 (-1.27%)
SENSEX▼78,782.24
-941.88 (-1.18%)
NIFTY BANK▼51,215.25
-458.65 (-0.89%)
TATA MOTORS▼824.10
-19.35 (-2.29%)
SUZLON ENERGY▼66.32
-1.82 (-2.67%)
TATA STEEL▼146.95
-2.80 (-1.87%)
INDIAN RAILWAY FINANCE CORP▼153.24
-4.87 (-3.08%)
TATA POWER▼429.05
-16.40 (-3.68%)
RAIL VIKAS NIGAM▼446.20
-24.75 (-5.26%)
RELIANCE INDUSTRIES▼1,302.15
-36.50 (-2.73%)
VODAFONE IDEA▼7.88
-0.57 (-6.75%)
ZOMATO▼245.08
-3.91 (-1.57%)
RELIANCE POWER▼42.03
-1.00 (-2.32%)
INDIAN RENEWABLE ENERGY▼205.38
-6.60 (-3.11%)
ADANI POWER▼585.00
-12.35 (-2.07%)
YES BANK▼20.33
-0.38 (-1.83%)
STATE BANK OF INDIA▲829.85
8.65 (1.05%)
NHPC▼83.30
-0.83 (-0.99%)
HDFC BANK▼1,714.10
-23.20 (-1.34%)
OLA ELECTRIC MOBILITY LTD▼80.84
-2.00 (-2.41%)
JIO FIN SERVICES LTD▼319.85
-6.35 (-1.95%)
INDIAN OIL CORP▼138.93
-6.06 (-4.18%)
BHARAT ELECTRONICS▼284.15
-4.50 (-1.56%)
MRF▼1,20,876.75
-2453.55 (-1.99%)
GTL INFRA▼2.11
-0.07 (-3.21%)
ADANI PORT & SEZ▼1,349.25
-45.15 (-3.24%)
JAIPRAKASH POWER VENTURES▼17.88
-0.59 (-3.19%)
ITC▼484.60
-5.70 (-1.16%)
AstraZeneca Pharma Ind Share Price
ASTRAZEN
₹7,351.45-₹199.50 (-2.64%) TodayLast updated on 04 Nov, 2024 | 15:51 IST
AstraZeneca Pharma Ind Share Price Chart
Please wait...
About AstraZeneca Pharma Ind
AstraZeneca Pharma Ind Financials
Market cap ₹19,062 Crs | Open ₹7,550.00 | Close ₹7,550.95 |
Circuit range ₹8,821.70 - ₹5,881.20 | Day range ₹7,215.55 - ₹7,550.00 | Year range ₹4,510.00 - ₹8,139.00 |
Volume 11,789 | Avg. traded ₹7,415.01 | Revenue (12m) ₹1,388 Crs |
AstraZeneca Pharma IndAstraZeneca Pharma India Limited is an India-based biopharmaceutical company. Its therapeutic areas include cardiovascular, renal and metabolism; oncology, and respiratory diseases. The Company operates through Healthcare segment. The Company is engaged in the business of manufacturing, distribution and marketing of pharmaceutical products and also provides clinical trial services to an overseas group company. Its therapeutic offerings in CVRM business include heart failure, and chronic kidney disease indications for Forxiga (Dapagliflozin). Its approvals in oncology business include the use of Imfinzi (Durvalumab) in Biliary Tract Carcinoma, and use of Lynparza (Olaparib) in early breast cancer. The Company has a portfolio of oral antidiabetic drugs with presence in two drug classes: SGLT2 inhibitors and DPP4 inhibitors. The Company’s DPP4 offering comprises of the brands of Onglyza (Saxagliptin) and Kombiglzye (Saxagliptin/Metformin).
Astrazeneca Pharma Ind Key indicators
52 week high ₹8,139.00 | 52 week low ₹4,510.00 | P/E ratio 198.86 |
P/B ratio 26.52 | ROE 24.95% | ROCE 33.94% |
Dividend yield 0.32% | Debt/Equity ratio | EPS 64.6 |
Learn more
Featured in
Investment checklist: (5/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
AstraZeneca Pharma Ind Fundamentals
AstraZeneca Pharma Ind Financial Ratios
Operating profit margin16.84% | Net profit margin12.4% |
ROE24.95% | ROA13.35% |
ROCE33.94% |
Learn more
Astrazeneca Pharma Ind Share Price history
Day | Open | Close | Change % |
---|---|---|---|
Mon, Nov 4 2024 | ₹7,550.00 | ₹7,351.45 | -2.64% |
Fri, Nov 1 2024 | ₹7,600.00 | ₹7,550.95 | -0.97% |
Thu, Oct 31 2024 | ₹7,305.00 | ₹7,624.90 | |
Wed, Oct 30 2024 | ₹7,340.70 | ₹7,339.10 | -0.01% |
Tue, Oct 29 2024 | ₹7,088.25 | ₹7,340.00 | |
Mon, Oct 28 2024 | ₹7,142.20 | ₹7,060.80 | -1.14% |
Fri, Oct 25 2024 | ₹7,155.05 | ₹7,142.20 | -0.18% |
Thu, Oct 24 2024 | ₹7,223.25 | ₹7,155.25 | -0.94% |
Events
Corporate actions
Dividend • ₹24/share
Ex date 05 Jul 2024
Dividend • ₹16/share
Ex date 14 Jul 2023
Dividend • ₹8/share
Ex date 07 Jul 2022
Learn more
More